BIOS Capital Management, LP
An institutional investment manager in Fort Worth, TX. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1813845.
- Reported value$41.7m
- Positions6
Holdings: 6 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 9 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Actuate Therapeutics IncACTU | COM | 005083100 | 15.4 | 36.9% | 10,049,996 | Unchanged | |
| Opus Genetics IncIRD | COM | 67577R102 | 15.1 | 36.3% | 3,683,429 | Unchanged | |
| Cognition Therapeutics IncCGTX | COM | 19243B102 | 6.9 | 16.6% | 6,000,000 | Unchanged | |
| Rein Therapeutics IncRNTX | COM NEW | 00887A204 | 3.1 | 7.4% | 2,982,375 | Added+1,000,000 | |
| Lantern Pharma IncLTRN | COM | 51654W101 | 1.0 | 2.5% | 249,397 | Reduced−615,038 | |
| IN8BIO IncINAB | COM NEW | 45674E208 | 0.1 | 0.3% | 80,957 | Reduced−86,848 |
Source: SEC EDGAR, Form 13F-HR, accession 0001813845-26-000004 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.